During the past decade, Tianjin Medical University Eye Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 1 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tianjin Medical University Eye Hospital" #1 sponsor was "Lv Yingjuan" with 5 trials, followed by "Tianjin Medical University Eye Hospital" with 4 trials sponsored, "Chengdu Kanghong Biotech Co., Ltd." with 3 trials sponsored, "Tianjin Medical University" with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tianjin Medical University Eye Hospital" #1 collaborator was "Peking University First Hospital" with 2 trials as a collaborator, "Beijing Municipal Science & Technology Commission" with 1 trials as a collaborator, "Cangzhou Eye Hospital" with 1 trials as a collaborator, "Hebei Provincial Eye Hospital" with 1 trials as a collaborator and "Oyster Point Pharma, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Tianjin Medical University Eye Hospital" are "Uveitis" (3 trials), "Diabetic Retinopathy" (2 trials), "Pars Plana Vitrectomy" (2 trials), "Primary Open- Angle Glaucoma" (2 trials) and "Proliferative Diabetic Retinopathy" (2 trials). Many other conditions were trialed in "Tianjin Medical University Eye Hospital" in a lesser frequency.

Most popular intervention types in "Tianjin Medical University Eye Hospital" are "Drug" (14 trials), "Other" (4 trials), "Procedure" (4 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vitamin D receptor polymorphic analysis" (2 trials), "601 1.25mg" (1 trials), "Acyclovir" (1 trials), "Adalimumab" (1 trials) and "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tianjin Medical University Eye Hospital" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Tianjin Medical University Eye Hospital". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Tianjin Medical University Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tianjin Medical University Eye Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".